United States Biotechnology & Medical Research

Palvella Therapeutics Inc (PVLA)

Track

Track

Palvella Therapeutics Inc experienced thirteen insider trading transactions over the past ninety days, all involving sales by Chief Operating Officer Kathleen Goin. These divestments totaled approximately 3.19 million dollars. Despite a recent earnings report missing expectations by 31%, the stock price surged 48.6%, currently trading near its fifty-two week peak.
Ticker: PVLA Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Palvella Therapeutics Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Goin Kathleen Chief Operating Officer Officer
Transaction date
Planned sale
Price
257.06
Quantity 9,816 -33.2%
Value US$3,387,001
Goin Kathleen Chief Operating Officer Officer
Transaction date
Planned sale
Price
341.84
Quantity 48,384 -16.6%
Value US$1,340,412
Goin Kathleen Chief Operating Officer Officer
Transaction date
Planned sale
Price
47.75
Quantity 45,322 +24.5%
Value US$1,529,485
Goin Kathleen Chief Operating Officer Officer
Transaction date
Planned sale
Price
147.14
Quantity 522 -12.1%
Value US$76,805
Goin Kathleen Officer Officer
Transaction date
Proposed sale
Price
149.68
Quantity 4,302
Value US$643,923
Goin Kathleen Chief Operating Officer Officer
Transaction date
Planned sale
Price
112.23
Quantity 25 -100.0%
Value US$2,806
Goin Kathleen Chief Operating Officer Officer
Transaction date
Planned sale
Price
111.31
Quantity 1,887 -98.7%
Value US$210,047
Goin Kathleen Chief Operating Officer Officer
Transaction date
Planned sale
Price
110.26
Quantity 2,390 -55.6%
Value US$263,520
Goin Kathleen Officer Officer
Transaction date
Proposed sale
Price
110.73
Quantity 4,302
Value US$476,373
Goin Kathleen Chief Operating Officer Officer
Transaction date
Planned sale
Price
111.90
Quantity 48 -100.0%
Value US$5,371
Goin Kathleen Chief Operating Officer Officer
Transaction date
Planned sale
Price
111.30
Quantity 891 -94.9%
Value US$99,165
Goin Kathleen Chief Operating Officer Officer
Transaction date
Planned sale
Price
110.35
Quantity 3,363 -78.2%
Value US$371,095
Goin Kathleen Officer Officer
Transaction date
Proposed sale
Price
110.56
Quantity 4,302
Value US$475,631
Goin Kathleen Chief Operating Officer Officer
Transaction date
Planned sale
Price
130.33
Quantity 100 -100.0%
Value US$13,033
Goin Kathleen Chief Operating Officer Officer
Transaction date
Planned sale
Price
129.17
Quantity 639 -86.5%
Value US$82,539
Goin Kathleen Chief Operating Officer Officer
Transaction date
Planned sale
Price
128.23
Quantity 561 -43.2%
Value US$71,940
Goin Kathleen Chief Operating Officer Officer
Transaction date
Planned sale
Price
127.13
Quantity 1,500 -53.6%
Value US$190,688
Goin Kathleen Chief Operating Officer Officer
Transaction date
Planned sale
Price
125.96
Quantity 1,502 -34.9%
Value US$189,199
Goin Kathleen Officer Officer
Transaction date
Proposed sale
Price
129.53
Quantity 4,302
Value US$557,238
3.1
JENKINS GEORGE M Non-Executive Director
Transaction date
Purchase
Price
112.30
Quantity 445 +0.2%
Value US$49,974
Goin Kathleen Chief Operating Officer Officer
Transaction date
Planned sale
Price
119.08
Quantity 304 -100.0%
Value US$36,201
Goin Kathleen Chief Operating Officer Officer
Transaction date
Planned sale
Price
118.37
Quantity 1,730 -85.1%
Value US$204,777
Goin Kathleen Chief Operating Officer Officer
Transaction date
Planned sale
Price
117.56
Quantity 2,268 -52.7%
Value US$266,633
Goin Kathleen Officer Officer
Transaction date
Proposed sale
Price
120.80
Quantity 4,302
Value US$519,681
2.1
HERON ELAINE J Non-Executive Director
Transaction date
Purchase
Price
125.00
Quantity 2,400 +5.3%
Value US$300,000
3.1
JENKINS GEORGE M Non-Executive Director
Transaction date
Purchase
Price
125.00
Quantity 4,000 +2.2%
Value US$500,000
Goin Kathleen Chief Operating Officer Officer
Transaction date
Planned sale
Price
79.97
Quantity 1,276 -100.0%
Value US$102,035
Goin Kathleen Chief Operating Officer Officer
Transaction date
Planned sale
Price
79.16
Quantity 3,026 -70.3%
Value US$239,529
Goin Kathleen Officer Officer
Transaction date
Proposed sale
Price
80.09
Quantity 4,302
Value US$344,547
Goin Kathleen Officer Officer
Transaction date
Proposed sale
Price
80.09
Quantity 4,301
Value US$344,467
Goin Kathleen Chief Operating Officer Officer
Transaction date
Planned sale
Price
97.94
Quantity 3,749 -100.0%
Value US$367,177
Goin Kathleen Chief Operating Officer Officer
Transaction date
Planned sale
Price
95.49
Quantity 553 -12.9%
Value US$52,806
Goin Kathleen Officer Officer
Transaction date
Proposed sale
Price
98.01
Quantity 4,302
Value US$421,639
Goin Kathleen Chief Operating Officer Officer
Transaction date
Planned sale
Price
96.47
Quantity 4,302 -100.0%
Value US$415,023
Goin Kathleen Officer Officer
Transaction date
Proposed sale
Price
96.81
Quantity 4,302
Value US$416,477
Goin Kathleen Chief Operating Officer Officer
Transaction date
Planned sale
Price
86.51
Quantity 2,802 -100.0%
Value US$242,388
Goin Kathleen Chief Operating Officer Officer
Transaction date
Planned sale
Price
85.72
Quantity 1,500 -34.9%
Value US$128,577
Goin Kathleen Officer Officer
Transaction date
Proposed sale
Price
82.94
Quantity 4,302
Value US$356,808
3.1
JENKINS GEORGE M Non-Executive Director
Transaction date
Purchase
Price
20.27
Quantity 2,490 +22.6%
Value US$50,472
3.1
JENKINS GEORGE M Non-Executive Director
Transaction date
Purchase
Price
20.13
Quantity 2,500 +1.4%
Value US$50,325
3.1
JENKINS GEORGE M Non-Executive Director
Transaction date
Purchase
Price
12.93
Quantity 4,000 +2.3%
Value US$51,720
0.5
KIRITSY CHRISTOPHER P Non-Executive Director
Transaction date
Purchase
Price
0.85
Quantity 10,000 +100.0%
Value US$8,500
0.9
Demuth Tim Chief Medical Officer Officer
Transaction date
Purchase
Price
1.71
Quantity 6,000 +inf%
Value US$10,260
2.6
Olwill Shane Chief Development Officer Officer
Transaction date
Sale
Price
5.15
Quantity 29,200 -86.3%
Value US$150,380
2.6
Olwill Shane Chief Development Officer Officer
Transaction date
Sale
Price
5.00
Quantity 9,200 -21.4%
Value US$46,000
4.0
BVF PARTNERS L P/IL Large shareholder
Transaction date
Sale
Price
4.50
Quantity 1,128 -0.4%
Value US$5,075
4.0
BVF PARTNERS L P/IL Large shareholder
Transaction date
Sale
Price
4.50
Quantity 25,720 -1.1%
Value US$115,725
4.0
BVF PARTNERS L P/IL Large shareholder
Transaction date
Sale
Price
4.50
Quantity 23,152 -1.0%
Value US$104,170
KIRITSY CHRISTOPHER P
Transaction date
Purchase
Price
5.11
Quantity 5,000 +100.0%
Value US$25,525
GERAGHTY JAMES A
Transaction date
Purchase
Price
5.75
Quantity 10,000 +100.0%
Value US$57,500
ORBIMED ADVISORS LLC Large shareholder
Transaction date
Sale
Price
6.35
Quantity 10,400 -21.1%
Value US$66,040
ORBIMED ADVISORS LLC Large shareholder
Transaction date
Sale
Price
6.35
Quantity 989,600 -18.0%
Value US$6,283,960
ORBIMED ADVISORS LLC Large shareholder
Transaction date
Sale
Price
8.98
Quantity 75 -0.2%
Value US$674
ORBIMED ADVISORS LLC Large shareholder
Transaction date
Sale
Price
8.98
Quantity 7,822 -0.1%
Value US$70,242
ORBIMED ADVISORS LLC Large shareholder
Transaction date
Sale
Price
7.35
Quantity 16,128 -24.7%
Value US$118,541
ORBIMED ADVISORS LLC Large shareholder
Transaction date
Sale
Price
7.35
Quantity 1,693,492 -23.5%
Value US$12,447,166
ORBIMED ADVISORS LLC Large shareholder
Transaction date
Sale
Price
5.70
Quantity 1,392 -2.1%
Value US$7,934
ORBIMED ADVISORS LLC Large shareholder
Transaction date
Sale
Price
5.70
Quantity 146,243 -2.0%
Value US$833,585
GERAGHTY JAMES A
Transaction date
Purchase
Price
4.82
Quantity 10,000 +inf%
Value US$48,200
Reine Allan See Remarks
Transaction date
Purchase
Price
4.89
Quantity 20,000 +44.4%
Value US$97,800
Reine Allan See Remarks
Transaction date
Purchase
Price
4.79
Quantity 45,000 +inf%
Value US$215,550
Matis Louis SVP, Chief Development Officer Officer
Transaction date
Purchase
Price
1.71
Quantity 7,915 +379.6%
Value US$13,535
Matis Louis SVP, Chief Development Officer Officer
Transaction date
Purchase
Price
1.68
Quantity 2,085 +inf%
Value US$3,503
Yoder Stephen S. President and CEO Executive Director
Transaction date
Purchase
Price
1.68
Quantity 6,000 +inf%
Value US$10,080
DEPTULA-HICKS DARLENE M SVP, Chief Financial Officer Officer
Transaction date
Purchase
Price
1.66
Quantity 5,000 +inf%
Value US$8,300
ORBIMED ADVISORS LLC Non-Executive Director Large shareholder
Transaction date
Purchase
Price
2.75
Quantity 4,717 +7.8%
Value US$12,972
Khuong Chau Quang Non-Executive Director Large shareholder
Transaction date
Purchase
Price
2.75
Quantity 4,717 +7.8%
Value US$12,972
ORBIMED ADVISORS LLC Non-Executive Director Large shareholder
Transaction date
Purchase
Price
2.75
Quantity 495,283 +7.4%
Value US$1,362,028
Khuong Chau Quang Non-Executive Director Large shareholder
Transaction date
Purchase
Price
2.75
Quantity 495,283 +7.4%
Value US$1,362,028
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-07-17 2026-07-15 PlS Planned sale
Goin Kathleen

Chief Operating Officer

Officer
9,816 -33.2%
257.06
US$3,387,001 		9,816 -33.2% 257.06 US$3,387,001
2026-07-17 2026-07-15 PlS Planned sale
Goin Kathleen

Chief Operating Officer

Officer
48,384 -16.6%
341.84
US$1,340,412 		48,384 -16.6% 341.84 US$1,340,412
2026-07-17 2026-07-15 PlS Planned sale
Goin Kathleen

Chief Operating Officer

Officer
45,322 +24.5%
47.75
US$1,529,485 		45,322 +24.5% 47.75 US$1,529,485
2026-07-17 2026-07-15 PlS Planned sale
Goin Kathleen

Chief Operating Officer

Officer
522 -12.1%
147.14
US$76,805 		522 -12.1% 147.14 US$76,805
2026-07-15 2026-07-15 PrS Proposed sale
Goin Kathleen

Officer

Officer
4,302
149.68
US$643,923 		4,302 149.68 US$643,923
2026-06-22 2026-06-17 PlS Planned sale
Goin Kathleen

Chief Operating Officer

Officer
25 -100.0%
112.23
US$2,806 		25 -100.0% 112.23 US$2,806
2026-06-22 2026-06-17 PlS Planned sale
Goin Kathleen

Chief Operating Officer

Officer
1,887 -98.7%
111.31
US$210,047 		1,887 -98.7% 111.31 US$210,047
2026-06-22 2026-06-17 PlS Planned sale
Goin Kathleen

Chief Operating Officer

Officer
2,390 -55.6%
110.26
US$263,520 		2,390 -55.6% 110.26 US$263,520
2026-06-17 2026-06-17 PrS Proposed sale
Goin Kathleen

Officer

Officer
4,302
110.73
US$476,373 		4,302 110.73 US$476,373
2026-05-22 2026-05-20 PlS Planned sale
Goin Kathleen

Chief Operating Officer

Officer
48 -100.0%
111.90
US$5,371 		48 -100.0% 111.90 US$5,371
2026-05-22 2026-05-20 PlS Planned sale
Goin Kathleen

Chief Operating Officer

Officer
891 -94.9%
111.30
US$99,165 		891 -94.9% 111.30 US$99,165
2026-05-22 2026-05-20 PlS Planned sale
Goin Kathleen

Chief Operating Officer

Officer
3,363 -78.2%
110.35
US$371,095 		3,363 -78.2% 110.35 US$371,095
2026-05-20 2026-05-20 PrS Proposed sale
Goin Kathleen

Officer

Officer
4,302
110.56
US$475,631 		4,302 110.56 US$475,631
2026-04-17 2026-04-15 PlS Planned sale
Goin Kathleen

Chief Operating Officer

Officer
100 -100.0%
130.33
US$13,033 		100 -100.0% 130.33 US$13,033
2026-04-17 2026-04-15 PlS Planned sale
Goin Kathleen

Chief Operating Officer

Officer
639 -86.5%
129.17
US$82,539 		639 -86.5% 129.17 US$82,539
2026-04-17 2026-04-15 PlS Planned sale
Goin Kathleen

Chief Operating Officer

Officer
561 -43.2%
128.23
US$71,940 		561 -43.2% 128.23 US$71,940
2026-04-17 2026-04-15 PlS Planned sale
Goin Kathleen

Chief Operating Officer

Officer
1,500 -53.6%
127.13
US$190,688 		1,500 -53.6% 127.13 US$190,688
2026-04-17 2026-04-15 PlS Planned sale
Goin Kathleen

Chief Operating Officer

Officer
1,502 -34.9%
125.96
US$189,199 		1,502 -34.9% 125.96 US$189,199
2026-04-15 2026-04-15 PrS Proposed sale
Goin Kathleen

Officer

Officer
4,302
129.53
US$557,238 		4,302 129.53 US$557,238
2026-04-01 2026-03-30 B Purchase
3.1
JENKINS GEORGE M
Non-Executive Director
445 +0.2%
112.30
US$49,974 		445 +0.2% 112.30 US$49,974
2026-03-20 2026-03-18 PlS Planned sale
Goin Kathleen

Chief Operating Officer

Officer
304 -100.0%
119.08
US$36,201 		304 -100.0% 119.08 US$36,201
2026-03-20 2026-03-18 PlS Planned sale
Goin Kathleen

Chief Operating Officer

Officer
1,730 -85.1%
118.37
US$204,777 		1,730 -85.1% 118.37 US$204,777
2026-03-20 2026-03-18 PlS Planned sale
Goin Kathleen

Chief Operating Officer

Officer
2,268 -52.7%
117.56
US$266,633 		2,268 -52.7% 117.56 US$266,633
2026-03-18 2026-03-18 PrS Proposed sale
Goin Kathleen

Officer

Officer
4,302
120.80
US$519,681 		4,302 120.80 US$519,681
2026-03-02 2026-02-27 B Purchase
2.1
HERON ELAINE J
Non-Executive Director
2,400 +5.3%
125.00
US$300,000 		2,400 +5.3% 125.00 US$300,000
2026-03-02 2026-02-27 B Purchase
3.1
JENKINS GEORGE M
Non-Executive Director
4,000 +2.2%
125.00
US$500,000 		4,000 +2.2% 125.00 US$500,000
2026-02-20 2026-02-18 PlS Planned sale
Goin Kathleen

Chief Operating Officer

Officer
1,276 -100.0%
79.97
US$102,035 		1,276 -100.0% 79.97 US$102,035
2026-02-20 2026-02-18 PlS Planned sale
Goin Kathleen

Chief Operating Officer

Officer
3,026 -70.3%
79.16
US$239,529 		3,026 -70.3% 79.16 US$239,529
2026-02-19 2026-02-18 PrS Proposed sale
Goin Kathleen

Officer

Officer
4,302
80.09
US$344,547 		4,302 80.09 US$344,547
2026-02-18 2026-02-18 PrS Proposed sale
Goin Kathleen

Officer

Officer
4,301
80.09
US$344,467 		4,301 80.09 US$344,467
2026-01-23 2026-01-21 PlS Planned sale
Goin Kathleen

Chief Operating Officer

Officer
3,749 -100.0%
97.94
US$367,177 		3,749 -100.0% 97.94 US$367,177
2026-01-23 2026-01-21 PlS Planned sale
Goin Kathleen

Chief Operating Officer

Officer
553 -12.9%
95.49
US$52,806 		553 -12.9% 95.49 US$52,806
2026-01-21 2026-01-21 PrS Proposed sale
Goin Kathleen

Officer

Officer
4,302
98.01
US$421,639 		4,302 98.01 US$421,639
2025-12-19 2025-12-17 PlS Planned sale
Goin Kathleen

Chief Operating Officer

Officer
4,302 -100.0%
96.47
US$415,023 		4,302 -100.0% 96.47 US$415,023
2025-12-17 2025-12-17 PrS Proposed sale
Goin Kathleen

Officer

Officer
4,302
96.81
US$416,477 		4,302 96.81 US$416,477
2025-11-21 2025-11-19 PlS Planned sale
Goin Kathleen

Chief Operating Officer

Officer
2,802 -100.0%
86.51
US$242,388 		2,802 -100.0% 86.51 US$242,388
2025-11-21 2025-11-19 PlS Planned sale
Goin Kathleen

Chief Operating Officer

Officer
1,500 -34.9%
85.72
US$128,577 		1,500 -34.9% 85.72 US$128,577
2025-11-19 2025-11-19 PrS Proposed sale
Goin Kathleen

Officer

Officer
4,302
82.94
US$356,808 		4,302 82.94 US$356,808
2025-04-10 2025-04-09 B Purchase
3.1
JENKINS GEORGE M
Non-Executive Director
2,490 +22.6%
20.27
US$50,472 		2,490 +22.6% 20.27 US$50,472
2025-04-10 2025-04-09 B Purchase
3.1
JENKINS GEORGE M
Non-Executive Director
2,500 +1.4%
20.13
US$50,325 		2,500 +1.4% 20.13 US$50,325
2024-12-19 2024-12-18 B Purchase
3.1
JENKINS GEORGE M
Non-Executive Director
4,000 +2.3%
12.93
US$51,720 		4,000 +2.3% 12.93 US$51,720
2024-08-12 2024-08-12 B Purchase
4.0
ADAR1 Capital Management, LLC
Large shareholder
757 +5.3%
15.88
US$12,023 		757 +5.3% 15.88 US$12,023
2024-08-12 2024-08-12 B Purchase
4.0
ADAR1 Capital Management, LLC
Large shareholder
2,243 +1.8%
15.88
US$35,624 		2,243 +1.8% 15.88 US$35,624
2024-08-12 2024-08-09 B Purchase
4.0
ADAR1 Capital Management, LLC
Large shareholder
3,000 +2.4%
14.89
US$44,679 		3,000 +2.4% 14.89 US$44,679
2023-05-30 2023-05-25 B Purchase
0.5
KIRITSY CHRISTOPHER P
Non-Executive Director
10,000 +100.0%
0.85
US$8,500 		10,000 +100.0% 0.85 US$8,500
2022-05-16 2022-05-13 B Purchase
0.9
Demuth Tim

Chief Medical Officer

Officer
6,000 +inf%
1.71
US$10,260 		6,000 +inf% 1.71 US$10,260
2021-09-01 2021-08-30 S Sale
2.6
Olwill Shane

Chief Development Officer

Officer
29,200 -86.3%
5.15
US$150,380 		29,200 -86.3% 5.15 US$150,380
2021-09-01 2021-08-30 S Sale
2.6
Olwill Shane

Chief Development Officer

Officer
9,200 -21.4%
5.00
US$46,000 		9,200 -21.4% 5.00 US$46,000
2020-07-22 2020-07-21 S Sale
1.7
Aquilo Capital Management, LLC
Large shareholder
1,900,000 -34.1%
2.95
US$5,605,000 		1,900,000 -34.1% 2.95 US$5,605,000
2019-09-10 2019-09-06 S Sale
4.0
BVF PARTNERS L P/IL
Large shareholder
1,128 -0.4%
4.50
US$5,075 		1,128 -0.4% 4.50 US$5,075
2019-09-10 2019-09-06 S Sale
4.0
BVF PARTNERS L P/IL
Large shareholder
25,720 -1.1%
4.50
US$115,725 		25,720 -1.1% 4.50 US$115,725
2019-09-10 2019-09-06 S Sale
4.0
BVF PARTNERS L P/IL
Large shareholder
23,152 -1.0%
4.50
US$104,170 		23,152 -1.0% 4.50 US$104,170
2018-09-17 2018-09-14 B Purchase KIRITSY CHRISTOPHER P
5,000 +100.0%
5.11
US$25,525 		5,000 +100.0% 5.11 US$25,525
2018-05-16 2018-05-15 B Purchase GERAGHTY JAMES A
10,000 +100.0%
5.75
US$57,500 		10,000 +100.0% 5.75 US$57,500
2018-05-02 2018-04-30 S Sale ORBIMED ADVISORS LLC Large shareholder
10,400 -21.1%
6.35
US$66,040 		10,400 -21.1% 6.35 US$66,040
2018-05-02 2018-04-30 S Sale ORBIMED ADVISORS LLC Large shareholder
989,600 -18.0%
6.35
US$6,283,960 		989,600 -18.0% 6.35 US$6,283,960
2018-02-15 2018-02-13 S Sale ORBIMED ADVISORS LLC Large shareholder
75 -0.2%
8.98
US$674 		75 -0.2% 8.98 US$674
2018-02-15 2018-02-13 S Sale ORBIMED ADVISORS LLC Large shareholder
7,822 -0.1%
8.98
US$70,242 		7,822 -0.1% 8.98 US$70,242
2018-01-04 2018-01-03 S Sale ORBIMED ADVISORS LLC Large shareholder
16,128 -24.7%
7.35
US$118,541 		16,128 -24.7% 7.35 US$118,541
2018-01-04 2018-01-03 S Sale ORBIMED ADVISORS LLC Large shareholder
1,693,492 -23.5%
7.35
US$12,447,166 		1,693,492 -23.5% 7.35 US$12,447,166
2017-12-20 2017-12-18 S Sale ORBIMED ADVISORS LLC Large shareholder
1,392 -2.1%
5.70
US$7,934 		1,392 -2.1% 5.70 US$7,934
2017-12-20 2017-12-18 S Sale ORBIMED ADVISORS LLC Large shareholder
146,243 -2.0%
5.70
US$833,585 		146,243 -2.0% 5.70 US$833,585
2017-08-17 2017-08-17 B Purchase GERAGHTY JAMES A
10,000 +inf%
4.82
US$48,200 		10,000 +inf% 4.82 US$48,200
2017-08-17 2017-08-17 B Purchase Reine Allan

See Remarks
20,000 +44.4%
4.89
US$97,800 		20,000 +44.4% 4.89 US$97,800
2017-08-17 2017-08-16 B Purchase Reine Allan

See Remarks
45,000 +inf%
4.79
US$215,550 		45,000 +inf% 4.79 US$215,550
2016-06-15 2016-06-14 B Purchase Matis Louis

SVP, Chief Development Officer

Officer
7,915 +379.6%
1.71
US$13,535 		7,915 +379.6% 1.71 US$13,535
2016-06-15 2016-06-13 B Purchase Matis Louis

SVP, Chief Development Officer

Officer
2,085 +inf%
1.68
US$3,503 		2,085 +inf% 1.68 US$3,503
2016-06-15 2016-06-13 B Purchase Yoder Stephen S.

President and CEO

Executive Director
6,000 +inf%
1.68
US$10,080 		6,000 +inf% 1.68 US$10,080
2016-06-15 2016-06-13 B Purchase DEPTULA-HICKS DARLENE M

SVP, Chief Financial Officer

Officer
5,000 +inf%
1.66
US$8,300 		5,000 +inf% 1.66 US$8,300
2015-07-08 2015-07-06 B Purchase ORBIMED ADVISORS LLC Non-Executive Director Large shareholder
4,717 +7.8%
2.75
US$12,972 		4,717 +7.8% 2.75 US$12,972
2015-07-08 2015-07-06 B Purchase Khuong Chau Quang Non-Executive Director Large shareholder
4,717 +7.8%
2.75
US$12,972 		4,717 +7.8% 2.75 US$12,972
2015-07-08 2015-07-06 B Purchase ORBIMED ADVISORS LLC Non-Executive Director Large shareholder
495,283 +7.4%
2.75
US$1,362,028 		495,283 +7.4% 2.75 US$1,362,028
2015-07-08 2015-07-06 B Purchase Khuong Chau Quang Non-Executive Director Large shareholder
495,283 +7.4%
2.75
US$1,362,028 		495,283 +7.4% 2.75 US$1,362,028
Explore more

More insider trading research around Palvella Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America